Oasmia Pharmaceutical Pink Sheet Forecast - Naive Prediction
| OASMY Stock | USD 0.01 0.00 0.00% |
Oasmia Pink Sheet outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Oasmia Pharmaceutical's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Oasmia Pharmaceutical hype-based prediction, you can estimate the value of Oasmia Pharmaceutical AB from the perspective of Oasmia Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Oasmia Pharmaceutical AB on the next trading day is expected to be 0 with a mean absolute deviation of 0.0005 and the sum of the absolute errors of 0.03. Oasmia Pharmaceutical after-hype prediction price | USD 0.006953 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oasmia |
Oasmia Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Oasmia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oasmia using various technical indicators. When you analyze Oasmia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Oasmia Pharmaceutical Naive Prediction Price Forecast For the 27th of January
Given 90 days horizon, the Naive Prediction forecasted value of Oasmia Pharmaceutical AB on the next trading day is expected to be 0 with a mean absolute deviation of 0.0005, mean absolute percentage error of 0.00000062, and the sum of the absolute errors of 0.03.Please note that although there have been many attempts to predict Oasmia Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Oasmia Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Oasmia Pharmaceutical Pink Sheet Forecast Pattern
| Backtest Oasmia Pharmaceutical | Oasmia Pharmaceutical Price Prediction | Buy or Sell Advice |
Oasmia Pharmaceutical Forecasted Value
In the context of forecasting Oasmia Pharmaceutical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Oasmia Pharmaceutical's downside and upside margins for the forecasting period are 0.00005 and 8.84, respectively. We have considered Oasmia Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Oasmia Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Oasmia Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 103.8104 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 5.0E-4 |
| MAPE | Mean absolute percentage error | 0.0727 |
| SAE | Sum of the absolute errors | 0.0304 |
Predictive Modules for Oasmia Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oasmia Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oasmia Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Oasmia Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oasmia Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Oasmia Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oasmia Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Oasmia Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oasmia Pharmaceutical's historical news coverage. Oasmia Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.00 and 8.78, respectively. We have considered Oasmia Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oasmia Pharmaceutical is out of control at this time. Analysis and calculation of next after-hype price of Oasmia Pharmaceutical is based on 3 months time horizon.
Oasmia Pharmaceutical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Oasmia Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oasmia Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oasmia Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.59 | 8.84 | 0.00 | 0.04 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 39.06 |
|
Oasmia Pharmaceutical Hype Timeline
Oasmia Pharmaceutical is now traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.04. Oasmia is expected to increase in value after the next headline, with the price projected to jump to 0.006953 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is estimated to be 39.06%, whereas the daily expected return is now at -1.59%. The volatility of related hype on Oasmia Pharmaceutical is about 32813.66%, with the expected price after the next announcement by competition of 0.05. The company has a current ratio of 6.66, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Oasmia Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Oasmia Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oasmia Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oasmia to invest in growth at high rates of return. When we think about Oasmia Pharmaceutical's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next expected press release will be uncertain. Check out Historical Fundamental Analysis of Oasmia Pharmaceutical to cross-verify your projections.Oasmia Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Oasmia Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Oasmia Pharmaceutical's future price movements. Getting to know how Oasmia Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oasmia Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VPHIF | Valeo Pharma | 0.01 | 7 per month | 0.00 | (0.13) | 0.00 | 0.00 | 66.67 | |
| CHHE | China Health Industries | 0.12 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BQST | BioQuest Corp | 0.01 | 6 per month | 0.00 | (0.14) | 0.00 | 0.00 | 49.00 | |
| ECGS | Eco Growth Strategies | 0.00 | 0 per month | 0.00 | (0.01) | 36.00 | (27.69) | 153.46 | |
| MCUJF | Medicure | 0.12 | 2 per month | 0.00 | 0.07 | 5.62 | (3.23) | 33.09 | |
| LUFFF | Luff Enterprises | 0.00 | 0 per month | 0.00 | 0.17 | 60.00 | 0.00 | 1,899 | |
| MYCOF | Mydecine Innovations Group | 0.00 | 0 per month | 0.00 | 0.13 | 20.00 | 0.00 | 3,203 | |
| TRUFF | Red Light Holland | 0.01 | 4 per month | 0.00 | (0.08) | 14.29 | (12.00) | 34.84 | |
| OPGN | OpGen Inc | (0.0006) | 3 per month | 0.00 | 0.12 | 72.10 | (30.65) | 1,319,944 | |
| EGRX | Eagle Pharmaceuticals | 0.00 | 3 per month | 17.90 | 0.12 | 50.00 | (37.60) | 191.18 |
Other Forecasting Options for Oasmia Pharmaceutical
For every potential investor in Oasmia, whether a beginner or expert, Oasmia Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oasmia Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oasmia. Basic forecasting techniques help filter out the noise by identifying Oasmia Pharmaceutical's price trends.Oasmia Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oasmia Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Oasmia Pharmaceutical could also be used in its relative valuation, which is a method of valuing Oasmia Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oasmia Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Oasmia Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oasmia Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Oasmia Pharmaceutical pink sheet market strength indicators, traders can identify Oasmia Pharmaceutical AB entry and exit signals to maximize returns.
Oasmia Pharmaceutical Risk Indicators
The analysis of Oasmia Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oasmia Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oasmia pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.94 | |||
| Standard Deviation | 8.64 | |||
| Variance | 74.59 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Oasmia Pharmaceutical
The number of cover stories for Oasmia Pharmaceutical depends on current market conditions and Oasmia Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oasmia Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oasmia Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Oasmia Pharmaceutical Short Properties
Oasmia Pharmaceutical's future price predictability will typically decrease when Oasmia Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oasmia Pharmaceutical AB often depends not only on the future outlook of the potential Oasmia Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oasmia Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 448.4 M | |
| Shares Float | 134.6 M |
Additional Tools for Oasmia Pink Sheet Analysis
When running Oasmia Pharmaceutical's price analysis, check to measure Oasmia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oasmia Pharmaceutical is operating at the current time. Most of Oasmia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Oasmia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oasmia Pharmaceutical's price. Additionally, you may evaluate how the addition of Oasmia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.